Company: ARTL
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001640334-25-000825
Chunk: 126

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 1
Chunk 126
---
regulatory developments in the U.S. and internationally; ·the development, regulatory approval, efficacy and commercialization of competing product candidates; ·our ability to attract and retain key scientific or management personnel; ·the scope of protection we are able to establish and maintain for intellectual property rights covering our products and technology; ·the terms and conditions of licenses granted to us and our ability to license additional intellectual property related to our product candidates, as appropriate; ·potential claims related to our intellectual property; ·the accuracy of our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; ·our ability to maintain compliance with Nasdaq listing requirements; ·our ability to develop and maintain our corporate infrastructure, including our internal controls; ·our ability to develop innovative new product candidates; and ·our financial performance.

 15Table of Contents

Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item 1A. “Risk Factors” of this Quarterly Report on Form 10-Q. Given these uncertainties, you should not place undue reliance on these forward-looking statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this Quarterly Report on Form 10-Q. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

In addition, statements that include terms such as “we believe” and similar terms reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this filing, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

Our interim financial statements are stated in USD and are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). The following discussion should be read in conjunction with our financial statements and the